Technical Analysis for DEST - Destiny Pharma Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | -20.93% | |
| Wide Bands | Range Expansion | -20.93% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -22.73% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -22.73% | |
| Inside Day | Range Contraction | -22.73% | |
| Wide Bands | Range Expansion | -22.73% | |
| MACD Bullish Signal Line Cross | Bullish | -26.09% | |
| Wide Bands | Range Expansion | -26.09% | |
| Up 3 Days in a Row | Strength | -26.09% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -20.00% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 5 hours ago |
| 5x Volume Pace | about 7 hours ago |
| 3x Volume Pace | about 7 hours ago |
| 2x Volume Pace | about 7 hours ago |
| 1.5x Volume Pace | about 7 hours ago |
Get a Trading Assistant
Destiny Pharma Plc Description
Destiny Pharma PLC is a United Kingdom-based clinical stage biotechnology company. The Company is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. The exeporfinium chloride (XF) Drug series is the Company’s anti-microbial drug platform and comprises the related XF and drugs described by Destiny Pharma (DPD) drug candidate. Its pipeline for the XF Drug products includes XF-73 Nasal, XF-73 Throat, XF-70 Dermal and XF-70 Lung. XF-73 is a synthetic dicationic porphyrin derivative with antibacterial activity. XF-73 is in the clinical development stage for the prevention of post-surgical staphylococcal infections. XF-73 has completed four Phase I /II A studies in Europe.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Derivative Biotechnology Medicine Disease Pipe Clinic Drugs Xf Infection Infectious Disease Prevention Antibiotic Medication Infectious Infections Bacteria Antimicrobial Resistance G Series Stage Biotechnology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 83.78 |
| 52 Week Low | 15.55 |
| Average Volume | 352,837 |
| 200-Day Moving Average | 50.74 |
| 50-Day Moving Average | 30.35 |
| 20-Day Moving Average | 23.16 |
| 10-Day Moving Average | 20.05 |
| Average True Range | 2.36 |
| RSI (14) | 38.27 |
| ADX | 30.71 |
| +DI | 22.58 |
| -DI | 30.65 |
| Chandelier Exit (Long, 3 ATRs) | 25.53 |
| Chandelier Exit (Short, 3 ATRs) | 22.62 |
| Upper Bollinger Bands | 29.95 |
| Lower Bollinger Band | 16.38 |
| Percent B (%b) | 0.38 |
| BandWidth | 58.57 |
| MACD Line | -3.10 |
| MACD Signal Line | -3.63 |
| MACD Histogram | 0.5265 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 22.79 | ||||
| Resistance 3 (R3) | 22.78 | 22.35 | 22.58 | ||
| Resistance 2 (R2) | 22.35 | 22.02 | 22.35 | 22.50 | |
| Resistance 1 (R1) | 21.92 | 21.82 | 21.71 | 21.93 | 22.43 |
| Pivot Point | 21.49 | 21.49 | 21.38 | 21.49 | 21.49 |
| Support 1 (S1) | 21.06 | 21.16 | 20.85 | 21.07 | 20.57 |
| Support 2 (S2) | 20.63 | 20.96 | 20.63 | 20.50 | |
| Support 3 (S3) | 20.20 | 20.63 | 20.43 | ||
| Support 4 (S4) | 20.21 |
